Abstract
Anti-cardiolipin antibodies (anti-CL) in patients with hepatitis C virus (HCV) infection are independent of beta2-glycoprotein I (b2GPI) co-factor or features of antiphospholipid syndrome (APS)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have